Mode
Text Size
Log in / Sign up

ferric citrate

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ferric citrate

8 trials tracked of ferric citrate: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 6 citations.

8Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 2 2 Other / NA 2
  1. Phase 3 KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD Completed · 6 cited
  2. Phase 4 Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients Completed
  3. Phase 3 A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis Completed
  4. Phase 3 A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Completed
  5. Phase 2 A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) Completed
  6. Phase 2 Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis Completed
Show 2 more trials
  1. N/A Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Completed
  2. N/A Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.